Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropa Metals Regulatory News (EUZ)

  • This share is currently suspended. It was suspended at a price of 1.025
  • There is currently no data for EUZ

Directorate Change

25 Jan 2017 07:00

RNS Number : 0209V
Ferrum Crescent Ltd
25 January 2017
 

 

25 January 2017

Ferrum Crescent Limited

("Ferrum Crescent", the "Company" or the "Group")(ASX, AIM, JSE: FCR)

 

Ferrum Crescent Board Changes

 

 

Ferrum Crescent, the ASX, AIM and JSE quoted metals project developer, today announces the resignation of Mr Klaus Borowski from the Board of Directors of the Company ("Board"). Mr Borowski has been a Non-Executive Director of the Company since IPO and now leaves the Board to pursue other interests.

 

The Company is pleased to announce the appointment of Mr Laurence Read to the Board as a Non-Executive Director of Ferrum Crescent. Mr Read, a UK resident, has acted as a strategic and communications consultant to Ferrum Crescent for seven years, during which time he has contributed significantly to the Company. He will continue in this role as Non-Executive Director. He has sixteen years' experience in advising public and private companies on investor relations, in particular in the natural resources sector.

 

Both changes to the Board are with immediate effect.

 

Commenting today Justin Tooth, Executive Chairman, said: "On behalf of the Board, I would like to thank Klaus for all his commitment and work at Ferrum Crescent over the past ten years. We wish him well in retirement. As the Company progresses with the development of its assets, we welcome Laurence Read to the Board of Ferrum, noting his contribution in the recent developments of the Company as a consultant. We have a strong team on the Board and in senior management and I look forward to updating the market on our operational news shortly."

 

The following additional information is provided in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies in relation to the appointment of Laurence Read:

 

 

Laurence Thomas Martin Read (aged 40)

 

Current Directorships / Partnerships

Past Directorships / Partnerships (last 5 years)

Bezant Resources Plc

TERN Plc

Mowbrai Ltd

Mineral & Financial Investments Limited

Ixis Resources Ltd

 

 

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ('MAR').

 

 

For further information on the Company, please visit www.ferrumcrescent.com or contact:

 

Ferrum Crescent Limited

Justin Tooth, Executive Chairman

Grant Button, Director and Company Secretary T: +61 8 9474 2995

 

UK enquiries:

Laurence Read (UK representative) T: +44 7557 672 432

 

Strand Hanson Limited (Nominated Adviser)

Rory Murphy/Matthew Chandler T: +44 (0) 20 7409 3494

 

Beaufort Securities Limited (Broker)

Elliot Hance T: +44 (0) 20 7382 8300

 

Bravura Capital (Pty) Ltd (JSE Sponsor)

Doné Hattingh T (direct): +27 11 459 5037

 

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMGZMMDDGNZZ
Date   Source Headline
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn
11th Nov 20202:00 pmRNSPrice Monitoring Extension
2nd Nov 20207:00 amRNSNotice of Annual General Meeting
19th Oct 20207:00 amRNSGrant Awarded to Europa Metals
9th Oct 20207:00 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSFinal Results for the Year Ended 30 June 2020
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20202:05 pmRNSSecond Price Monitoring Extn
29th Sep 20202:00 pmRNSPrice Monitoring Extension
4th Sep 20201:25 pmRNSHolding(s) in Company
1st Sep 20209:20 amRNSHolding(s) in Company
1st Sep 20209:20 amRNSHolding(s) in Company
28th Aug 20207:00 amRNSMetallurgical Testing and Ore Sorting Results
19th Aug 20202:00 pmRNSInvestor Presentation
19th Aug 20207:00 amRNSEquity Fundraising of £2,000,000
14th Aug 20207:00 amRNSUpdated Resource Estimate
11th Aug 20207:00 amRNSProduct Marketing Agreement
5th Aug 20207:00 amRNSBoard Changes & Update re: Current Work Programmes
30th Jul 20202:05 pmRNSSecond Price Monitoring Extn
30th Jul 20202:00 pmRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSStatement re Share Price Increases Post GM
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20202:06 pmRNSSecond Price Monitoring Extn
27th Jul 20202:00 pmRNSPrice Monitoring Extension
24th Jul 20209:45 amRNSIssue of Options and Directors' Dealings
22nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
15th Jul 20201:15 pmRNSResults of General Meeting and Share Consolidation
12th Jun 202010:00 amRNSNotice of GM and Proposed Share Consolidation
8th Jun 20207:00 amRNSUpdate re:Investigation Permit, Toral Project
16th Apr 20207:00 amRNSMetallurgical Update
31st Mar 20202:05 pmRNSSecond Price Monitoring Extn
31st Mar 20202:00 pmRNSPrice Monitoring Extension
30th Mar 20209:30 amRNSHalf-year Report
27th Mar 20207:00 amRNSMetallurgical Update
23rd Mar 20207:00 amRNSImpact of Coronavirus on the Group's Operations
11th Mar 20207:00 amRNSAssay Results, Toral Project, Spain
28th Feb 20207:00 amRNSHydrogeological Study Completed
14th Feb 20207:00 amRNSGeotechnical Study Completed, Toral Project, Spain
31st Jan 20207:00 amRNSDrilling Update
22nd Jan 20207:00 amRNSOperational and Strategic Update
20th Dec 20197:00 amRNSBroker change
18th Dec 20197:00 amRNSPreliminary Metallurgical Results
5th Dec 20197:00 amRNSDrilling & Metallurgical Update, Toral Project
28th Nov 201911:00 amRNSResult of AGM
19th Nov 201910:00 amRNSCommencement of drilling at the Toral Project
15th Nov 20197:00 amRNSDrilling Mobilisation and Operational Update
5th Nov 20197:00 amRNSMail-out of Notice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.